Ohno Tatsuya, Kato Shingo, Wakatsuki Masaru, Noda Shin-Ei, Murakami Chiemi, Nakamura Misako, Tsujii Hirohiko
Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, 4-9-1 Anagawa, Chiba 263-8555, Japan.
Gynecol Oncol. 2006 Oct;103(1):94-9. doi: 10.1016/j.ygyno.2006.01.048. Epub 2006 Mar 9.
To investigate the temporal patterns of anorexia, diarrhea, weight loss, and leukopenia in chemoradiation therapy (CRT) for cervical cancer compared with radiation therapy (RT) alone.
Acute toxicities in 43 patients receiving RT alone and 40 patients receiving CRT were retrospectively analyzed. Patients were treated with a combination of external beam irradiation and high-dose rate intracavitary irradiation. Cisplatin was given once a week for 5 weeks concurrently with the external beam irradiation. CRT was divided into low-dose CRT group (cisplatin, 20-30 mg/m(2), n = 16) and high-dose CRT group (cisplatin, 35-40 mg/m(2), n = 24). Toxicities were evaluated before, every week up to 7 weeks during the cycle, and 12 weeks after initial irradiation, according to the National Cancer Institute Common Toxicity Criteria version 2.
In the high-dose CRT group, anorexia during the first 5 weeks, leukopenia after 5 weeks, and weight loss after 3 weeks were significantly higher than those in the RT alone group. In the low-dose CRT group, anorexia between 1 and 2 weeks, leukopenia after 5 weeks, and weight loss between 3 and 4 weeks were significantly higher than those in the RT alone group. Diarrhea between 1 and 2 weeks in the high-dose CRT group (P = 0.037, P = 0.025) and between 2 and 3 weeks in the low-dose CRT group (P = 0.015, P = 0.036) was significantly lower compared with RT alone.
These data can help us understand when patients are likely to develop maximal toxicities and to manage them with optimal timing.
与单纯放疗(RT)相比,研究宫颈癌放化疗(CRT)过程中厌食、腹泻、体重减轻和白细胞减少的时间模式。
回顾性分析43例接受单纯RT和40例接受CRT患者的急性毒性反应。患者接受外照射和高剂量率腔内照射联合治疗。顺铂在每周一次,共5周,与外照射同时进行。CRT分为低剂量CRT组(顺铂,20 - 30mg/m²,n = 16)和高剂量CRT组(顺铂,35 - 40mg/m²,n = 24)。根据美国国立癌症研究所通用毒性标准第2版,在治疗前、治疗周期内直至7周每周以及初始照射后12周评估毒性反应。
在高剂量CRT组中,前5周的厌食、5周后的白细胞减少以及3周后的体重减轻均显著高于单纯RT组。在低剂量CRT组中,1至2周的厌食、5周后的白细胞减少以及3至4周的体重减轻均显著高于单纯RT组。高剂量CRT组1至2周的腹泻(P = 0.037,P = 0.025)和低剂量CRT组2至3周的腹泻(P = 0.015,P = 0.036)与单纯RT组相比显著更低。
这些数据有助于我们了解患者何时可能出现最大毒性反应,并在最佳时机进行处理。